Research Article

A High Level of Circulating Valine Is a Biomarker for Type 2 Diabetes and Associated with the Hypoglycemic Effect of Sitagliptin

Figure 3

Sitagliptin treatment decreased valine levels in T2D patients. The relative level of valine in the T2D_Placebo and T2D_Sit groups. Data are presented as the , -test.